The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II study of a PARP inhibitor, talazoparib, in HER2- metastatic breast cancer (MBC) with a somatic BRCA1/2mutation identified in a cell-free DNA or tumor tissue genotyping assay.
 
Neelima Vidula
Consulting or Advisory Role - AADi; Gilead Sciences; OncoSec; Stemline Therapeutics; Tersera
Research Funding - DAEHWA Pharmaceutical (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst)
 
Senthil Damodaran
Consulting or Advisory Role - AstraZeneca; Taiho Oncology
Research Funding - AstraZeneca (Inst); Daiichi Sankyo/Astra Zeneca (Inst); DualityBio (Inst); EMD Serono (Inst); Guardant Health (Inst); MediLink Therapeutics (Inst); Novartis (Inst); Sermonix Pharmaceuticals (Inst); Taiho Pharmaceutical (Inst)
 
Manali A. Bhave
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Gilead Sciences; Lilly; Merck; Pfizer
 
Erica Blouch
No Relationships to Disclose
 
Ogadinma Ogbenna
No Relationships to Disclose
 
Lisa E. Flaum
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - AstraZeneca
 
Ami N. Shah
Honoraria - Gilead Sciences
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Gilead Sciences
 
Vandana G Abramson
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Guardant Health
Research Funding - Bayer; Guardant Health
 
Massimo Cristofanilli
Honoraria - Pfizer
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; Celcuity; Lilly; Menarini; Olaris; Sermonix Pharmaceuticals; Syantra
Research Funding - Angle; AstraZeneca; Lilly; Menarini Silicon Biosystems; Merck
 
Joseph A. Sparano
Consulting or Advisory Role - AstraZeneca; Genentech/Roche; General Dynamics Information Technology (GDIT); Lyell Immunopharma; Novartis; NSABP Foundation; Pfizer; Seagen
Research Funding - Olema Pharmaceuticals (Inst)
 
Harry Ostrer
No Relationships to Disclose
 
Nora K. Horick
Employment - Northwest Biotherapeutics (I)
Stock and Other Ownership Interests - Northwest Biotherapeutics (I)
Patents, Royalties, Other Intellectual Property - An immediate family member holds patents, has patents pending, and receives royalties from a technology relating to health or medicine. (I)
 
Hope S. Rugo
Consulting or Advisory Role - Daiichi Sankyo; Eisai; Mylan; Napo Pharmaceuticals; Puma Biotechnology
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Daiichi Sankyo (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hoffmann-La Roche AG/Genentech, Inc (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Stemline Therapeutics (Inst); Taiho Oncology (Inst); Veru (Inst)
 
Aditya Bardia
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca; Genentech; Genentech/Roche (Inst); Gilead Sciences; Gilead Sciences (Inst); Innocrin Pharma (Inst); Lilly; Lilly (Inst); Menarini; Menarini (Inst); Merck; Mersana; Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health (Inst); Sanofi
Research Funding - AstraZeneca/Daiichi Sankyo (Inst); Genentech (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Sanofi (Inst)